相似文献
1
Plant production of veterinary vaccines and therapeutics.
Curr Top Microbiol Immunol. 2009;332:79-102. doi: 10.1007/978-3-540-70868-1_5.
2
Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview.
Transgenic Res. 2007 Jun;16(3):315-32. doi: 10.1007/s11248-007-9095-x. Epub 2007 Apr 14.
3
Plant-based oral vaccines: results of human trials.
Curr Top Microbiol Immunol. 2009;332:103-17. doi: 10.1007/978-3-540-70868-1_6.
4
Research advances on transgenic plant vaccines.
Yi Chuan Xue Bao. 2006 Apr;33(4):285-93. doi: 10.1016/S0379-4172(06)60053-X.
5
Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives.
Vaccine. 2003 Jan 30;21(7-8):803-8. doi: 10.1016/s0264-410x(02)00603-5.
6
Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants.
Vaccine. 2000 Apr 3;18(19):2023-8. doi: 10.1016/s0264-410x(99)00525-3.
7
A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine.
Vaccine. 2004 Jun 23;22(19):2420-4. doi: 10.1016/j.vaccine.2003.11.066.
8
Expression systems and developments in plant-made vaccines.
Immunol Cell Biol. 2005 Jun;83(3):271-7. doi: 10.1111/j.1440-1711.2005.01336.x.
9
Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies.
Hum Vaccin. 2011 Mar;7(3):367-74. doi: 10.4161/hv.7.3.14303. Epub 2011 Mar 1.
10
Current state-of-the-art in the use of plants for the production of recombinant vaccines against infectious bursal disease virus.
Appl Microbiol Biotechnol. 2020 Mar;104(6):2287-2296. doi: 10.1007/s00253-020-10397-2. Epub 2020 Jan 24.
引用本文的文献
1
Plant-derived antigens as mucosal vaccines.
Curr Top Microbiol Immunol. 2012;354:101-20. doi: 10.1007/82_2011_158.
2
Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.
Plant Cell Rep. 2011 Aug;30(8):1367-82. doi: 10.1007/s00299-011-1065-3. Epub 2011 Apr 20.
3
Enhancing oral vaccine potency by targeting intestinal M cells.
PLoS Pathog. 2010 Nov 11;6(11):e1001147. doi: 10.1371/journal.ppat.1001147.
本文引用的文献
1
Bovine CD14 receptor produced in plants reduces severity of intramammary bacterial infection.
FASEB J. 2006 Jul;20(9):1345-51. doi: 10.1096/fj.05-5295com.
2
Plant-based immunocontraceptive control of wildlife--"potentials, limitations, and possums".
Vaccine. 2005 Mar 7;23(15):1847-50. doi: 10.1016/j.vaccine.2004.11.016.
3
Immunoprotective properties of transgenic plants expressing E2 glycoprotein from CSFV and cysteine protease from Fasciola hepatica.
Vaccine. 2005 Mar 7;23(15):1844-6. doi: 10.1016/j.vaccine.2004.11.015.
4
Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen.
Vaccine. 2005 Mar 7;23(15):1838-43. doi: 10.1016/j.vaccine.2004.11.014.
5
Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus.
J Biotechnol. 2004 Jul 15;111(2):121-30. doi: 10.1016/j.jbiotec.2004.03.012.
6
Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants.
J Gen Virol. 2004 Jul;85(Pt 7):1825-1832. doi: 10.1099/vir.0.19659-0.
7
Systemic and oral immunogenicity of hemagglutinin protein of rinderpest virus expressed by transgenic peanut plants in a mouse model.
Virology. 2004 Jun 1;323(2):284-91. doi: 10.1016/j.virol.2004.02.030.
8
A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine.
Vaccine. 2004 Jun 23;22(19):2420-4. doi: 10.1016/j.vaccine.2003.11.066.
9
On risk and plant-based biopharmaceuticals.
Trends Biotechnol. 2004 Feb;22(2):64-6. doi: 10.1016/j.tibtech.2003.11.007.
10
Plant production systems for vaccines.
Expert Rev Vaccines. 2003 Dec;2(6):763-75. doi: 10.1586/14760584.2.6.763.
Zotero 插件